Apogee Therapeutics
APGE
#2986
Rank
NZ$9.24 B
Marketcap
NZ$135.26
Share price
0.95%
Change (1 day)
57.95%
Change (1 year)

Apogee Therapeutics (APGE) - P/B ratio

P/B ratio as of January 2026 : 9.12

According to Apogee Therapeutics's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Apogee Therapeutics - P/B ratio (from 2023 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-319.01147.74%
2024-12-313.64-2.42%
2023-12-313.73
2022-12-31N/A